H2 PHARMA FRANCE (Biotechnology, Manufacturing) — Funding, Investors & Signals 2026

H2 PHARMA FRANCE

Spécialiste Français de la fabrication des produits "liquides non-stériles".

Founded 2009 France

France 57 employees Private Equity Total: $3.20M Biotechnology, Manufacturing +1

H2 PHARMA FRANCE, founded in 2009, has solidified its position as a leading figure in the Biotechnology, Manufacturing, and Pharmaceutical industries. The company specializes in the production of "liquides non-stériles" and is renowned as the go-to partner for generic pharmaceutical companies in France and key OTC pharmaceutical laboratories.

With its headquarters based in France, H2 PHARMA FRANCE is often referred to as the benchmark in its market segment. This reputation is supported by its dedication to quality and innovation, making it a critical player among its peers.

In terms of financial backing, the company was last supported by a Private Equity Round investment from Ardian on 20 October 2020, further endorsing its potential for growth and stability. For investors, H2 PHARMA FRANCE represents a robust opportunity in a niche yet essential segment of the pharmaceutical industry, underscored by a well-established market presence and significant industry partnerships.

Funding Stage	Amount	Investors	Lead Investors	Date
Private Equity Round	••••••	1		20 Oct 2020
Private Equity Round	••••••	1		01 Nov 2005

Funding Stage

Amount

Investors

Lead Investors

Date

Private Equity Round

••••••

20 Oct 2020

Private Equity Round

••••••

01 Nov 2005

FAQ About H2 PHARMA FRANCE

Spécialiste Français de la fabrication des produits "liquides non-stériles".

H2 PHARMA FRANCE was founded in 2009.

H2 PHARMA FRANCE is headquartered in France.

H2 PHARMA FRANCE operates in the following industries: Biotechnology, Manufacturing, Pharmaceutical.

H2 PHARMA FRANCE has approximately 57 employees.

H2 PHARMA FRANCE has completed 2 funding rounds, raising a total of $3.20M. The latest funding stage is Private Equity.

H2 PHARMA FRANCE offers: Sourcing of Active Ingredients, Pharmaceutical Development, Regulatory Affairs, Manufacturing, Conditioning, Serialization, Quality Assurance.

Top alternatives and competitors to H2 PHARMA FRANCE include Seratec, Bimedoc, MELISANA PHARMA, Serviphar | Groupe Neftys Pharma, Laboratoires BEKER®. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

H2 PHARMA FRANCE and Seratec are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

H2 PHARMA FRANCE

General Information

Track H2 PHARMA FRANCE

Discover More

About H2 PHARMA FRANCE

Services & Products

Target Customers

Funding Rounds & Investors (2)

H2 PHARMA FRANCE Alternatives & Competitors

FAQ About H2 PHARMA FRANCE

Don't just browse. Track.